Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hyosung Chemical Corporation (298000.KS)
Seoul, KR
Based in Seoul, South Korea, Hyosung Chemical Corporation manufactures and distributes a diverse array of chemical solutions across both domestic and global markets. The company supplies various grades of polypropylene (PP) under its TOPILENE brand, including PP/DH, PP-R, and PP-B. These versatile polymers are utilized in numerous applications such as piping, medical devices, clear packaging, specialized films, compounding, heat-resistant components, and bottle caps. Furthermore, its portfolio includes nylon films tailored for food preservation and general packaging for a multitude of household goods. Hyosung Chemical also produces PET films, essential for electrical and electronic components, alongside diverse industrial uses including specialized packaging and optical products. The corporation provides high-purity terephthalic acid, a crucial base material for manufacturing polyester fibers, tire cords, PET bottles, and polyester films. Its offerings extend to NF3 and other specialized industrial gases vital for advanced technology sectors like semiconductors, display panels, and solar energy devices. Moreover, the company produces tri-acetyl cellulose films for Liquid Crystal Displays (LCDs) and the advanced POKETONE polymer.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +41.39% | -29.31% | -9.69% | -9.69% | -9.69% | -9.69% | -9.69% | -45.54% | -84.24% | -63.21% | -63.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-17.5% Q1'26: -4.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+221.0% ★ Q1'26: -101.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-4.1% Q1'26: -16.8% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-9.8% Q1'26: +0.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%-12.1% Q1'26: +0.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.3% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-35.19× Q1'26: 7.93× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.12T
est: 1.56T (-28.6%)
|
1.81T
est: 1.83T (-0.9%)
|
1.82T
est: 1.84T (-1.1%)
|
2.45T
est: 2.48T (-1.0%)
|
2.88T
est: 2.99T (-3.6%)
|
2.79T
est: 2.88T (-3.0%)
|
2.84T
est: 3.39T (-16.2%)
|
2.34T
est: 3.20T (-26.8%)
|
| EBITDA |
138.12B
est: 132.80B (+4.0%)
|
303.86B
est: 155.36B (+95.6%)
|
223.88B
est: 156.09B (+43.4%)
|
328.05B
est: 210.54B (+55.8%)
|
-59.27B
est: 258.67B (-122.9%)
|
49.81B
est: 249.20B (-80.0%)
|
37.71B
est: 293.40B (-87.1%)
|
-45.66B
est: 277.12B (-116.5%)
|
| EBIT |
48.46B
est: -8.07B (+700.2%)
|
146.53B
est: -9.44B (+1,651.4%)
|
46.95B
est: -9.49B (+594.7%)
|
136.53B
est: -12.80B (+1,166.7%)
|
-347.15B
est: -10.42B (-3,232.4%)
|
-195.46B
est: -10.04B (-1,847.5%)
|
-183.24B
est: -11.82B (-1,450.7%)
|
-228.77B
est: -11.16B (-1,949.8%)
|
| Net Income |
20.39B
est: 44.99B (-54.7%)
|
87.82B
est: 97.70B (-10.1%)
|
-11.62B
est: 14.27B (-181.4%)
|
58.42B
est: 113.67B (-48.6%)
|
-408.87B
est: -131.16B (-211.7%)
|
-346.91B
est: -312.45B (-11.0%)
|
-325.72B
est: 58.32B (-658.5%)
|
393.10B
est: 243.11B (+61.7%)
|
| SGA |
19.62B
est: 31.35B (-37.4%)
|
35.60B
est: 36.68B (-2.9%)
|
34.97B
est: 36.85B (-5.1%)
|
38.57B
est: 49.71B (-22.4%)
|
43.85B
est: 50.98B (-14.0%)
|
48.59B
est: 49.12B (-1.1%)
|
41.68B
est: 57.83B (-27.9%)
|
32.05B
est: 54.62B (-41.3%)
|
| EPS |
6,412.35
est: 13,758.40 (-53.4%)
|
27,636.00
est: 29,876.75 (-7.5%)
|
-3,655.52
est: 4,364.80 (-183.8%)
|
18,382.00
est: 34,758.80 (-47.1%)
|
-128,663.67
est: -40,110.00 (-220.8%)
|
-106,720.99
est: -82,681.50 (-29.1%)
|
-86,182.00
est: 15,381.00 (-660.3%)
|
104,270.00
est: 64,112.00 (+62.6%)
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.00% | 22.5K | 0.15% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 192.0K | 0.06% |
| 3 | Vanguard FTSE Pacific ETF VPL | 0.00% | 59.6K | 0.07% |
| 4 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 16.2K | 0.23% |
| 5 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 1.4K | 0.22% |
| 6 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 45.0K | 0.33% |
| 7 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 741.38 | 0.22% |
| 8 | Vanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged) VEF.TO | 0.00% | 1.1K | 0.22% |
| 9 | Vanguard FTSE Developed Markets ETF VEA | 0.00% | 388.9K | 0.03% |
| 10 | Vanguard Total International Stock ETF VXUS | 0.00% | 621.3K | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheon-Seok Lee | Executive Director | — | male |
| Kun-Jong Lee | Chief Executive Officer & Executive Chairman | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 298000.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
